Agoracom Blog Home

Posts Tagged ‘$TSXV’

St-Georges Eco-Mining $SX $SX.ca $SXOOF Announces Termination of #ZeU’s Asset Purchase Agreement with Tiande and Updates Spin-Out Listing $HIVE.ca $BLOC.ca $CODE.ca

Posted by AGORACOM-JC at 8:45 AM on Monday, August 13th, 2018

Sx large

  • Subsidiary ZeU Crypto Networks Inc. has received a termination notice for the asset purchase agreement dated February 23, 2018, as amended May 17, 2018, among ZeU, Qingdao Tiande Technologies Limited, an affiliate of Beijing Tiande Technologies Limited’s
  • Termination notice received by ZeU was accompanied by a request to negotiate a new agreement.
  • A negotiation team composed of Vilhjalmur T. Vilhjalmsson and Mark Billings was appointed to review new proposals.

Montreal, Quebec / August 13, 2018 – St-Georges Eco-Mining Corp. (CSE: SX) (OTC: SXOOF) (FSE: 85G1) announces that its subsidiary ZeU Crypto Networks Inc. (“ZeU”) has received a termination notice for the asset purchase agreement dated February 23, 2018, as amended May 17, 2018, among ZeU, Qingdao Tiande Technologies Limited, an affiliate of Beijing Tiande Technologies Limited’s (collectively “Tiande”), with the intervention of Guiyang Tiande Technologies Limited, pursuant to which ZeU agreed to purchase the rights (the “Rights”) to substantially all the intellectual property of Tiande, as more particularly described in St-Georges February 26 and May 22, 2018 press releases.

The termination notice received by ZeU was accompanied by a request to negotiate a new agreement. A negotiation team composed of Vilhjalmur T. Vilhjalmsson and Mark Billings was appointed to review new proposals. Unfortunately, despite significant concessions offered by ZeU to negotiate and finalize a new agreement, the demands made by Tiande were simply not possible to accommodate in terms of both commercial viability and securities regulations. The overriding and irreconcilable factor was the unprecedented demand by Tiande that St-Georges somehow bears alone the financial burden of the downturn in blockchain and cryptocurrency valuations over the past six months. These revised and unreasonable financial demands by Tiande rendered the transaction commercially impossible for ZeU and very unlikely to have received the acceptance of regulatory authorities during the listing process.

To this end, ZeU has commenced the process of consulting with its legal advisors to seek full reimbursement and compensation of its expenses, as well as, to review potential actions on behalf of its shareholders.

CURRENT STATUS OF ZEU

The current status of ZeU is as follows. First, it still holds an exclusive license to use Qingdao Tiande Technologies Limited and Beijing Tiande Technologies Limited’s (collectively “Tiande”) proprietary technologies, patents and know-how to develop and commercialize novel mineral commodity production chain control, tracking and trading exchanges. Second, as a result of work product over this past 6 months, ZeU has a number of meaningful commercial opportunities available to pursue, including MOU’s that have already been signed with clients that are still willing to negotiate definitive agreements. As such, ZeU intends to pursue its listing process on the CSE.

MANAGEMENT CHANGES TO FOCUS OPERATIONS

As a result of the continuing development of ZeU, the following changes will be implemented effective immediately, Mark Billings will assume the position of Executive Chairman of St-Georges and Vilhjalmur T. Vilhjalmsson will assume the position of Interim President & CEO to fully focus their efforts on following up on the legal status of the transaction termination, the mineral exploration and processing technology development within St-Georges. Frank Dumas will focus his time on St-Georges’ subsidiaries, ZeU Crypto Networks Inc. and Borealis EHF in the capacity of President to accelerate the numerous current opportunities and developments.

ZeU management understands that shareholders will have many questions over the coming days and will provide full accessibility via its CEO Verified Discussion Forum on AGORACOM at https://agoracom.com/ir/St-GeorgesEco-MiningTechnologies/forums/discussion where shareholders can post questions and/or read answers in a fully transparent manner. Shareholders are asked to post their questions and management will address them when the answers become available.

ON BEHALF OF THE BOARD OF DIRECTORS

“Mark Billings”

MARK BILLINGS, EXECUTIVE CHAIRMAN

About St-Georges

St-Georges is developing new technologies to solve the some of the most common environmental problems in the mining industry.

The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

The release contains forwarding looking information and statements as defined by law including, without limitation, Canadian securities laws and the “safe harbor” provisions of the US Private Securities Litigation Reform Act of 1995 (“forward-looking statements”), respecting St-Georges’ plans to spin-out its subsidiary ZeU. which is intended to be listed on the Canadian Securities Exchange. Forward-looking statements involve risks, uncertainties and other factors that may cause actual results to materially differ from those expressed or implied by the forward-looking statements including that the spin-out may not be completed as planned or at all due to failure to obtain shareholder or regulatory approval ,the inability to complete the Acquisition, raise sufficient capital to adequately fund ZeU or a decision of the board of St-Georges not to proceed, which decision can be made at any time prior to closing. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and a number of assumptions that may prove to be incorrect, including, without limitation, assumptions about general business and economic conditions, the timing and receipt of required approval and continued availability of capital and financing. Readers are cautioned not to place undue reliance on the forward-looking statements contained herein. The foregoing list is not exhaustive and St-Georges undertakes no obligation to update any of the foregoing except as required by law.

Copyright (c) 2018 TheNewswire – All rights reserved.

betterU Education Corporation $BTRU.ca Has Been Advised That Closing of US$100 Million Investment Is Around the Corner $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 8:41 AM on Monday, August 13th, 2018

Betteru large

  • betterU has worked diligently to support the closing of the investment and continues to receive regular updates from TU Capital Co. Ltd. (“TUC”) on their progress
  • The CEO of TUC has confirmed that the fund management team have been in Tokyo Japan for the last couple of weeks and that they have executed on the final agreements for release of funds

OTTAWA, Aug. 13, 2018 – betterU Education Corp. (TSX-V:BTRU) (FRANKFURT:5OGA), (the “Corporation” or “betterU”), would like to provide an update on the investment progress.

betterU has worked diligently to support the closing of the investment and continues to receive regular updates from TU Capital Co. Ltd. (“TUC”) on their progress. The CEO of TUC has confirmed that the fund management team have been in Tokyo Japan for the last couple of weeks and that they have executed on the final agreements for release of funds. According to TUC communications shared with betterU, the Chairman of TUC has also agreed to stay in Tokyo until the fund transfers have been completed. “While these delays have been difficult for everyone involved, we are confident that the funding completion is closer than ever. The ongoing updates, progress reports and discussions from TUC has demonstrated their commitment to completion.” says Brad Loiselle, President and CEO betterU.

While betterU continues to support TUC’s timelines, the betterU team has also continued to advance their global partnerships, the development of new technology, the adding of more educational providers to their platform, the participation in global speaking engagements and much more. Stay tuned for more announcements as it pertains to these advancements.

The majority shareholder’s approval has been provided the Corporation. The consummation of any financing, as contemplated, remains subject to TSXV approval, and among other conditions of the TSXV’s approval.

About betterU

betterU, a global education to employment platform, aims to provide access to quality education from around the world to foster growth and opportunity to those who want to better their lives. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated education-to-employment ecosystem. betterU’s offerings can be categorized into several broad functions: to compliment school programs with flexible KG-12 programs preparing children for next stage of education, to provide access to global educational opportunities from leading educators, to foster an exceptional educational environment by providing befitting skills that lead to a better career, to bridge the gap between one’s existing education and prospective job requirement by training them and lastly, to connect the end user to various job opportunities.

www.betterU.ca and www.betterU.in

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release may contain forward-looking statements and information, which may involve risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Factors that might cause a difference include, but are not limited to, competitive developments, risks associated with betterU’s growth, the state of the financial markets, regulatory risks and other factors. There can be no assurance or guarantees that any statements of forward-looking information contained in this release will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral statements containing forward-looking information are based on the estimates and opinions of management on the dates they are made and expressly qualified in their entirety by this notice. Unless otherwise required by applicable securities laws, betterU disclaims any intention or obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise. Readers should not place undue reliance on any statements of forward-looking information that speak only as of the date of this release. Further information on betterU’s public filings, including their most recent audited consolidated financial statements, are available at www.sedar.com.

For further information, please visit  https://ir.betteru.ca/investor-overview/press-releases/

On behalf of the Board of Director,
better Education Corp.
Brad Loiselle, CEO

For further information:

Investor Relations
1-613-695-4100 Ext. 233
Email: [email protected]

Nvidia $NVDA opening #Esports boot camps in Germany and China $GMBL $ATVI $TTWO $GAME $EPY.ca $TCEHF $Game.ca $EPY.ca

Posted by AGORACOM-JC at 3:59 PM on Friday, August 10th, 2018
  • There’s no denying that eSports is a big business
  • This year, the industry is expected to see another jump in growth that will take overall revenues close to one billion dollars.
  • As such, competitors take their training extremely seriously, which is why Nvidia has opened two new international eSports boot camps.

By Rob Thubron, Today 9:37 AM

Back in 2015, Nvidia opened its GeForce eSports studio in Silicon Valley, letting those who are part of the scene prepare for tournaments on the same pro gaming systems used in competitions. It’s already hosted teams such as Tempo Storm, Team Secret compLexity Gaming, INTZ and Team USA. Now, the company is opening two more of these boot camps, in Munich and Shanghai.

The camps give players access to 240Hz G-Sync monitors, three meals per day, and “a dedicated environment for eSport athletes to train in.” With many eSports tournaments taking place across the world and with teams made up of international players, competitors are far from home and their loved ones for much of the year. Nvidia hopes its camps will help them concentrate on honing their game skills and team strategies as they prepare for battle.

“We want to make our visiting teams’ tournament preparation as fruitful as possible as they prep for tournaments like Valve’s The International, Perfect World, ESL, Starladder, PGL and League of Legends World Championships,” writes Nvidia.

Despite already being a massive industry, eSports continues to grow. This year has seen Ohio’s Ashland University announce it is offering up to $4000 eSports scholarships to students with a high “player skill level” and the appropriate academic requirements. Additionally, Epic Games recently said it would offer $100 million in prize pool funding for Fortnite’s “2018 – 2019” competitive season.

Source: https://www.techspot.com/news/75910-nvidia-opening-esports-boot-camps-germany-china.html

CLIENT FEATURE: Peeks Social $PEEK.ca Live Streaming App With $2.1M In Quarterly Revenue / 6.2M User Sessions $IDK.ca $BCOV $AVID

Posted by AGORACOM-JC at 3:21 PM on Friday, August 10th, 2018

WHAT IS PEEKS?

Peeks is a new live streaming app where people can interact and transact in real time by sending cash tips as appreciation for content and or selling goods and services to their live viewers.

HIGHLIGHTS

  • Platform generated gross revenue of $2.1 million during Q1 2019, up from $1.1 million during Q1 2018;
  • User sessions were 6.20 million for the three months ended May 31, 2018, as compared to 5.13 million for the three months ended May 31, 2017
  • Users generated $1.44 million in gross customer deposits to the Peeks Social platform during the three months ended May 31, 2018, as compared to $773k for the three months ended May 31, 2017

FULL DISCLOSURE: Peeks Social is an advertising client of AGORA Internet Relations Corp.

INTERVIEW: Liberty Star $LBSR Discusses Latest Activities in #Copper Mining Rich Southeast Arizona $TMBXF $MIN.ca

Posted by AGORACOM-JC at 8:57 AM on Friday, August 10th, 2018

Professional #Esports – Challenges and Solutions $GMBL $ATVI $TTWO $GAME $EPY.ca $TCEHF $Game.ca $EPY.ca

Posted by AGORACOM-JC at 10:15 AM on Thursday, August 9th, 2018
  • According to Forbes, the total income of the eSports industry grew from $493 million in 2016 to $655 million in 2017 and is expected to increase to over $900 million in 2018
  • Research conducted by SuperData and PayPal meanwhile reports that the total eSports audience grew by roughly 2 to 3 million people in the same period of time.

The last few years have seen eSports develop rapidly. According to Forbes, the total income of the eSports industry grew from $493 million in 2016 to $655 million in 2017 and is expected to increase to over $900 million in 2018. Research conducted by SuperData and PayPal meanwhile reports that the total eSports audience grew by roughly 2 to 3 million people in the same period of time. Companies such as CocaCola, Microsoft, Amazon, Tencent and many others are increasingly investing in eSports, in recognition of the industry’s huge growth potential, as well its unique appeal which has helped it grow an audience of millions. There may even come a day when esports competitions are held in the same regard as those of traditional sports.

The rise in popularity and market size of eSports has also seen a growing number of online gaming platforms emerge. These platforms allow players to become a part of the global gaming community, enabling them to share their experience, play with others, and even earn prizes. However, there are all too often drawbacks to these services, especially where earning from gaming is concerned, be it difficulty withdrawing funds, lack of transparency in the distribution of prize funds, and fraud on the part of third-party services. These problems, as well as many others, may be solved through the implementation of blockchain technology – a technology which has found applications in a variety of other areas and is now poised to bring its benefits to esports gaming.

Blockchain is a huge, constantly supplemented, decentralized database with shared access, which utilizes  a chain of blocks to store transaction data. Data is complementary across multiple blocks, meaning that data cannot be removed or replaced in a single location without altering it across every block. In addition to the lack of a single centralized storage, blockchain technology reduces the potential for hacking or fraudulent activity and is immunized against the threat of a single compromised unit compromising the entire database system.

Despite the potential advantages and benefits offered by blockchain technology, few online platforms have yet to take advantage of implementing blockchain technology. However, one such service currently under development, Cybercube, aims to take advantage of the benefits posed by blockchain technology by using it to build their service from the ground up. Speaking to the Cybercube team, we were able to find out just how blockchain technology can be used to solve the most pressing problems of the eSports industry.

  1. Unprotected rights of eSports participants

When creating tournaments, organizers often assign an entrance fee, helping to form the prize fund which is ultimately distributed amongst the tournament’s winner(s). However, outside of major, well-known tournaments, which the vast majority of players are unable to take part in, the distribution of prize pools is largely unregulated. Players often don’t see the promised winnings or are not paid at all. In addition, there are cases when the player plays worse than the rest of the team and, contrary to the agreement, the team deprives him of any compensation.

This particular issue may be solved by blockchain technology via the use of smart contracts – a computer algorithm which prescribes all the conditions for the distribution of prizes. Smart contracts ensure the transparency and execution of the terms of transactions, by automatically distributing prizes per pre-prescribed conditions, which thanks to the blockchain system, are available to all participants, and cannot be changed or altered by a single user or party. The contract code sets out key performance indicators for each player. After the completion of a game or tournament, these figures are automatically compared to the real indicators and, as a result of this comparison, the distribution of the winings occurs.If the indicators lag behind, the reward is automatically cut; if the indicators don’t lag, then the remuneration is calculated in full. Thus, the agreement in a smart contract can not be violated.

  1. Refusal of intermediaries in the payment of winnings

Whilst many players are keen to take part in solo tournaments, they may often become victims of fraud due to third parties, especially if they lack management. This is due to third parties withholding, refusing, or otherwise delaying the payment of winnings to players.

Smart contracts again help to mitigate these particular issues by allowing players to safely make contributions, collect winnings, and compete for prize funds without the need for third parties. Since smart contracts ensure that the distribution of winnings are prescribed in advance, players can be assured that they will be executed properly and quickly at the end of a tournament.

  1. Fraudulent behaviour within the skins market

Many players utilise the sale of valuable in-game items such as skins in order to earn money from gaming outside of tournaments. Today there exists a huge number of intermediaries and services which allow players to trade skins, though they nearly all have in common incredibly high commission rates, with some charging up to 20% per transaction. There also exist a huge number of fraudulent services, many of which can be hard for the average user to distinguish from legitimate ones.

Blockchain technology allows for the implementation of real-time blockchain auctions, which utilise the advantages of decentralised information storage to mitigate the potential for fraud, whilst also doing away with the need for third party services and hence needlessly high commission rates.

  1. Withdrawal of funds earned in-game

Most online games now offer rewards for players or some form of monetised in-game items, be it skins, weapons, clothing, or access to particular maps or game-modes. The cost of these items can vary hugely, from a few cents to tens of thousands of dollars, with the most-expensive skin sold to date, specifically Dragon Lore for CS:GO, selling for $61,000 dollars. Whilst the sale and purchase of skins is supported by established and reputable services such as Steam, the inability of users to withdraw funds from their Steam wallets means they are forced to seek out third party services in order to re-allocate funds to external accounts. These third party services, as is often the case, can charge high commissions, with players sometimes losing up to 50% of the original value of their funds by the time they have been re-allocated.

Blockchain meanwhile operates chiefly using cryptocurrencies, allowing for unprecedented access to and freedom in moving money around between a user’s accounts and wallets, without incurring commission or transaction fees, as well as being quick and secure to use. Cybcercube itself aims to utilise an internal currency which can be converted directly to cryptocurrencies such as Bitcoin or Ethereum to further increase the ease with which players and users can re-allocate their money.

  1. Donation chargebacks

Some gamers and prominent eSports figures choose to create and host streams, live broadcasts featuring gameplay and viewer interaction. These streams can attract thousands of concurrent viewers, and several major streaming services offer streamers the opportunity to build up consistent audiences and income streams through allowing viewers to subscribe to their particular streams. Viewers also often choose to donate to their favourite streamers of their own volition in order to support their favourite streamers. However, it is not uncommon for malicious viewers to donate to a streamer in order to request a chargeback – a request for the denial of a transaction and the return of funds to the original cardholder. Chargebacks can be used to harass streamers, particularly large chargebacks, since streamers are required to pay a commission on the return of chargeback donations.

Cybercube’s use of blockchain technology and cryptocurrencies does away with this issue. Since cryptocurrency transactions are decentralised and anonymous, the origin of transactions cannot necessarily be identified, removing the ability to conduct chargebacks, preventing chargebacks being enacted out of spite since those wishing to utilise them so cannot be guaranteed to have their fake donations returned to them.

Conclusion

Blockchain technology has the potential to radically transform the eSports industry. It offers a number of practical solutions and potential improvements to long-standing issues, offering more convenient and transparent alternatives to existing services. It isn’t surprising that the number of online gaming platforms that implement blockchain solutions in their work is constantly growing. The more gaming platforms adopt such a system of work, the sooner the moment of transition of the industry to cryptocurrency begins. It’s only a matter of time.

Source: https://www.newsbtc.com/2018/08/08/professional-esports-challenges-and-solutions/

Health Canada Gives Green Light to Tetra Bio-Pharma’s $TBP.ca #Cannabis Vs. #Fentanyl Trial $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:18 AM on Thursday, August 9th, 2018

  • Health Canada has approved its protocol for a clinical trial investigating its PPP001 drug as an alternative to the opioid fentanyl in the management of breakthrough cancer pain
  • The clinical trial will be conducted by Montreal-based Santé Cannabis, a medical clinic and contract research organization specialized in clinical research for cannabis – based therapies

Patient recruitment to begin for landmark research

ORLEANS, Ontario, Aug. 09, 2018 — Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that Health Canada has approved its protocol for a clinical trial investigating its PPP001 drug as an alternative to the opioid fentanyl in the management of breakthrough cancer pain.  The clinical trial will be conducted by Montreal-based Santé Cannabis, a medical clinic and contract research organization specialized in clinical research for cannabis – based therapies.

The trial will assess the time-to-relief in patients suffering from breakthrough cancer pain.  Based on its clinical data, Tetra believes that the pharmacodynamic properties of PPP001 may provide a novel faster acting alternative to the opioid fentanyl.  In addition, the time-to-maximal plasma concentrations of THC suggest that PPP001 will provide rapid relief to the patient’s suffering.  As a prescription drug with a Drug Identification Number (DIN) PPP001 will be eligible for insurance coverage, making the cannabis-based medication accessible in pharmacies thereby providing much easier access.

The Opioid Crisis

There have been numerous news reports in the North America media highlighting the fact that we are experiencing an opioid crisis. In June, the Canadian government asked drug makers to stop marketing opioids, but for patients suffering from uncontrolled pain, this news does not provide them with an alternative to alleviate their pain.

  • There were 41,997 opioid-related deaths in the USA in 2016 contributing to the U.S. President’s declaration that the U.S. is experiencing an opioid crisis.
  • 92% of the 3,987 apparent opioid-related deaths in Canada in 2017 were accidental.
  • Males make up 76% of these fatalities; more than one-third among those aged 30-39.
  • The percentage of these accidental deaths involving fentanyl rose from 55% in 2016 to 72% in 2017.

“Medical cannabis may help reduce the use of drugs like fentanyl for treating breakthrough and chronic pain. However, unrefuted scientific data on its safety and effectiveness that will satisfy regulators, professional groups and insurers is what’s missing,” said Dr. Guy Chamberland, Interim CEO and Chief Scientific Officer of Tetra Bio-Pharma.  “Tetra is in the business of providing that evidence which would see our drug PPP001 become a complementary prescription therapy.  We’ve taken a pharmaceutical pathway of drug development involving collaborative dialogue with Health Canada and the FDA to bring cannabis and cannabinoid products to market so that physicians, who have been hesitant to recommend it, will have a new, trusted therapeutic option for their patients.”

Cannabis versus Fentanyl Clinical Trial Recruitment
Santé Cannabis will begin recruitment for the clinical trial as of October 2018. More information on eligibility criteria as well as the details and duration of the trial can be obtained by visiting the Santé Cannabis website: www.santecannabis.ca/en/research/cannabis-clinical-trial/ or by calling 514-419-4131 and select English and press 5 to reach the research team.

About Tetra Bio-Pharma
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

For more information visit: www.tetrabiopharma.com

About Santé Cannabis
Established in Montreal, Quebec in 2014, Santé Cannabis is a Centre of Excellence in medical cannabis research, clinical practice and healthcare professional training. Since its inception, Santé Cannabis has provided medical assessment, education, monitoring and follow-up to 5,000 patients referred by more than 2,000 Quebec physicians. Santé Cannabis operates within the guidelines for the authorization of medical cannabis as set out by the Collège des médecins du Québec.   As an independently credentialed clinical trial research organization, and with unparalleled clinical experience supporting both patients and healthcare professionals, Santé Cannabis has established itself as a global leader in medical cannabis research. Santé Cannabis is currently conducting a Health Canada approved Phase 3 trial for PPP001 for advanced cancer patients suffering from uncontrolled pain and associated symptoms, as well as a Phase 2 trial for PPP005 investigating the use of oral capsules of cannabis oil for the treatment of chronic pain.

For more information visit:  www.santecannabis.ca

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, including this trial, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

For further information, please contact Tetra Bio-Pharma Inc.

Robert (Bob) Bechard
Executive Vice President, Corporate Development and Licensing
514-817-2514
[email protected]

Media Contact:
energi PR
Stephanie Engel
[email protected]
514-288-8500 ext. 209
416-425-9143 ext. 209

St-Georges Eco-Mining $SX $SX.ca $SXOOF Announces #Lithium Extraction Technology Licensing Agreement with Hipo Resources Ltd. for DRC Project

Posted by AGORACOM-JC at 4:27 PM on Wednesday, August 8th, 2018

Sx large

  • Signed a binding term sheet with Hipo Resources Ltd (ASX: HIP), a public company based in Australia
  • In consideration for the R&D, which will include engineering services, and once a definitive agreement has been entered into, Hipo Resources Ltd. will issue to St-Georges up to 27,000,000 common shares of its capital stock.

Montreal, Quebec /  August 8, 2018 – St-Georges Eco-Mining Ltd. (CSE: SX) (OTC: SXOOF) (FSE: 85G1) is pleased to announce that it has signed a binding term sheet with Hipo Resources Ltd (ASX: HIP), a public company based in Australia.

St-Georges has agreed to provide research and development utilizing products, extraction methods and proprietary technology to develop Hipo’s Democratic Republic of Congo lithium project in separation, recovery, and purification of lithium from its lithium-bearing material.

In consideration for the R&D, which will include engineering services, and once a definitive agreement has been entered into, Hipo Resources Ltd. will issue to St-Georges up to 27,000,000 common shares of its capital stock. The issuance will be done in stages over a 36-month period commencing on the date of execution of the definitive agreement, contingent on St-Georges reaching certain performance benchmarks over the 36-month period according to the schedule below:

1,500,000 shares at signing

8,500,000 shares at Stage 1 Benchmark completion: which is defined by the delivery of an independent laboratory report commissioned by St-Georges, indicating positive viable lithium recoveries.

8,500,000 shares at Stage 2 Benchmark completion: defined by independent report describing results of initial pilot mining operations and the processing of a minimum of one (1) metric ton in a simulated industrial environment.

8,500,000 shares at Stage 3 Benchmark completion: defined by the receipt of either: a Preliminary Economical Assessment Report (PEA); a commercialization decision; the third (3rd) year anniversary of this agreement assuming all other issuances have been made.

St-Georges has agreed that shares issued will be subject to a 36 months escrow period.

The Parties will establish a royalty stream on the commercial output of the Kamola Lithium Project for the entire mine life subject to Hipo using St-Georges technology, which will be opposable to any successors of Hipo as a lien on the mining assets. St-Georges and Hipo will negotiate a right of first refusal in favour of Hipo. The royalty, of which further details will be defined in the definitive agreement within the guidelines of the “Royalty Formula” of the binding term sheet, will take the form of a 5% Net Revenue Interest or Net Revenue Return.

A further news release will be disseminated once the definitive agreement has been concluded. The definitive agreement will be subject to acceptance of the board of directors of both companies and subject to review by regulatory authorities.

Enrico Di Cesare, VP, Metallurgy & Director of St-Georges commented “St-Georges continues to apply innovation with known technologies coupled with newly developed technologies to address gaps for the recovery of non-traditional lithium resources. Our focus remains greener, less chemicals and more usable by-products unlocking value in non-traditional resources as the next generation of lithium supply to the growing battery market and its needs for this commodity.

Di Cesare further stated “Innovation is being applied to concentrating Lithium in Bonnie Claire clay in Nevada USA, which is owned by Iconic Minerals Ltd (TSX-V: ICM). In addition, St-Georges is also looking to initiate development with similar strategies for hard rock deposits in North America and other parts of the world. We do value and look forward to working with Hipo Resources in advancing the lithium potential of their DRC project.”

ON BEHALF OF THE BOARD OF DIRECTORS

“Enrico Di Cesare”

ENRICO DI CESARE, DIRECTOR, VICE-PRESIDENT RESEARCH & DEVELOPMENT

About St-Georges

St-Georges is developing new technologies to solve the some of the most common environmental problems in the mining industry. The Company controls directly or indirectly, through rights of first refusal, all the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Head quartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

CLIENT FEATURE: Star Navigation $SNA.ca Real-Time Flight Tracking and Monitoring Technology

Posted by AGORACOM-JC at 4:15 PM on Wednesday, August 8th, 2018

STAR-A.D.S.®

  • On-board real-time monitoring and data analysis system that provides a “virtual window into an aircraft”
  • As cost-effective air to ground communication system that automatically and securely transmits flight data and incident alerts.
  • Continuously monitors selected avionics systems on the aircraft from power-on to power-off, instantly analyzes the data, and transmits selected data and any incident alerts, via satellite to the operator.
  • Acts as an early warning system, detecting the earliest signs of potential problems
  • Performs these functions in “real-time” providing essential safety monitoring to the benefit of passengers, aircraft personnel, and ground crew
  • Applications include: Commercial Airlines, Helicopters, Business Aircraft, Assist Search and Rescue by providing last transmitted location
  • Recent applications: Emergency Medical Services (airborne and ground vehicles), Land vehicles

CHECK OUT RECENT INTERVIEW

FULL DISCLOSURE: Star Navigation Systems Group Ltd. is an advertising client of AGORA Internet Relations Corp.

Tetra Bio-Pharma’s $TBP.ca Dr. Chamberland to Announce Health Canada’s Green Light for the #Cannabis vs. #Fentanyl Trial $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 2:26 PM on Wednesday, August 8th, 2018

Logo tetrabiopharma rgb web

  • Announced that Health Canada has approved its protocol for a clinical trial investigating its PPP001 drug as an alternative to the opioid fentanyl in the management of breakthrough cancer pain
  • Dr. Guy Chamberland, Interim CEO and Chief Scientific Officer will provide additional details on TVA’s Gatineau 6:00 p.m. ET News Program

ORLEANS, Ontario, Aug. 08, 2018 – Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that Health Canada has approved its protocol for a clinical trial investigating its PPP001 drug as an alternative to the opioid fentanyl in the management of breakthrough cancer pain. Dr. Guy Chamberland, Interim CEO and Chief Scientific Officer will provide additional details on TVA’s Gatineau 6:00 p.m. ET News Program. A more detailed press release will be issued tomorrow.

About Tetra Bio-Pharma
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com

More information at: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, including this trial, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

For further information, please contact Tetra Bio-Pharma Inc.

Robert (Bob) Bechard
Executive Vice President, Corporate Development and Licensing
514-817-2514
[email protected]

Media Contact:
energi PR
Stephanie Engel
[email protected]
514-288-8500 ext. 209
416-425-9143 ext. 209